Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.
about
Practical Guidance on How to Handle Levodopa/Carbidopa Intestinal Gel Therapy of Advanced PD in a Movement Disorder ClinicLevodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim results.Irregular gastrointestinal drug absorption in Parkinson's disease.Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management.New non-oral drug delivery systems for Parkinson's disease treatment.Future treatments for Parkinson's disease: surfing the PD pipeline.When the going gets tough: how to select patients with Parkinson's disease for advanced therapies.Continuous dopaminergic delivery to minimize motor complications in Parkinson's disease.Treatment of motor fluctuations in Parkinson's disease: recent developments and future directions.Apomorphine and levodopa infusion therapies for advanced Parkinson's disease.Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease.Best practice in placement of percutaneous endoscopic gastrostomy with jejunal extension tube for continuous infusion of levodopa carbidopa intestinal gel in the treatment of selected patients with Parkinson's disease in the Nordic region.Novel Approaches to Optimization of Levodopa Therapy for Parkinson's Disease.Transcutaneous port for levodopa/carbidopa intestinal gel administration in Parkinson's disease.Cutting the Gordian knot: the blockage of the jejunal tube, a rare complication of Duodopa infusion treatmentLevodopa/carbidopa/entacapone in Parkinson's disease.Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care.Therapy for dyskinesias in Parkinson’s disease patients
P2860
Q36120697-F4F71AB7-D65B-419A-B1E7-111A4D03539DQ36866618-EC85BA1F-FC5F-48E1-AABB-177F87B9E6C5Q37076343-366F4CBF-05C0-4B33-9D09-B569ACA21629Q37507973-2101E816-F264-4EDE-938A-9666B00507B1Q37840165-008F6166-F749-4FB9-9095-A6B60EEFDF6CQ37950428-44C9961A-6879-4650-8907-C1F46F002A68Q38089025-35BF3F15-EF4F-45FD-975F-0128FD4E874CQ38112219-5C13F2B1-17B8-4C91-8918-89545EB4A554Q38170421-FC695514-167A-46DF-B326-D276945BCDC8Q38215506-C7700410-9563-4990-9D90-38F13794EBCDQ38285126-C4F94BC9-54E9-4D8A-B5EC-263EF6951D62Q38530328-A938D8A4-D16F-4F7F-8679-31C087A4265EQ38742792-C9C15701-1C11-4CA8-9E92-31A0C70EDD43Q40694060-37702C6A-5999-4A86-BB54-6ECE26E7F590Q42161072-9CBA1830-1BB8-48F8-891F-5A0C4843752DQ45934197-CB009AA1-67E1-41AB-AEFE-FA2ADC82EF6EQ47652358-2496F7F3-1A46-4074-AB48-D3C4778A12F2Q48258968-6A2E0F9E-E905-4F2C-8AB6-4CA84E00658CQ57518128-D1DC6F25-F92E-4CCD-A94A-8167E84A6E9B
P2860
Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Enteral levodopa/carbidopa gel ...... advanced Parkinson's disease.
@ast
Enteral levodopa/carbidopa gel ...... advanced Parkinson's disease.
@en
type
label
Enteral levodopa/carbidopa gel ...... advanced Parkinson's disease.
@ast
Enteral levodopa/carbidopa gel ...... advanced Parkinson's disease.
@en
prefLabel
Enteral levodopa/carbidopa gel ...... advanced Parkinson's disease.
@ast
Enteral levodopa/carbidopa gel ...... advanced Parkinson's disease.
@en
P2860
P1476
Enteral levodopa/carbidopa gel ...... advanced Parkinson's disease.
@en
P2093
Dag Nyholm
P2860
P304
P356
10.1586/14737175.6.10.1403
P577
2006-10-01T00:00:00Z